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Abstract In lysates of the rat brain, the SNARE complex, a 
putative membrane fusion machinery of synaptic exocytosis, is 
extremely stable and is detected after SDS-PAGE. Applying this 
technique to parotid acinar cells, however, we could only detect 
the monomeric VAMP-2, but not the high molecular forms 
associated with other components of the SNARE complex. 
Parotid acini did not contain brain-type t-SNAREs, but 
contained NSF and ocSNAP. When VAMP-2 was immunopre-
cipitated from parotid acinar cell lysates, NSF and a S N A P were 
coprecipitated with it. Since NSF and a S N A P are unable to bind 
directly to VAMP-2 but indirectly bind via t-SNAREs, the 
immunoprecipitate very likely contained unidentified t-SNAREs. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Exocytosis is a fusion process of secretory granule mem-
branes with the plasma membrane. According to the most 
prevailing theory (SNARE hypothesis) [1-3], the iV-ethylma-
leimide-sensitive fusion protein (NSF) and soluble N S F at-
tachment proteins (oc,P,y-SNAPs) in the cytosolic fraction 
make a complex with the specific receptor proteins (SNAP 
receptors; SNAREs) on the vesicle membrane (v-SNAREs) 
and those on the target membrane ( t-SNAREs). The specific 
protein-protein interaction of the S N A R E complex is believed 
to lead to docking and fusion of secretory vesicles with their 
proper destination. In neuronal cells, vesicle-associated mem-
brane protein-2 (VAMP-2) is recognized as a v -SNARE on 
synaptic vesicles, and synaptosome-associated protein of 25 
k D a (SNAP-25) and syntaxin 1A/B are known as t -SNAREs 
on presynaptic membranes. In vitro reconstitution system, 
VAMP-2, SNAP-25, and syntaxins are tightly bound to 
form a 7S complex, and then make a 20S complex in the 
presence of N S F and SNAPs. These protein-protein interac-
tions have been established to be mediated via the predicted 
coiled-coil domain near the C-terminus of syntaxin; this do-
main binds SNAP-25, VAMP-2, and a S N A P that binds N S F . 
N S F has two A T P binding sites in each molecule and disso-
ciates the 20S S N A R E complex by hydrolyzing ATP. The 
ATPase activity of N S F plays an essential role in membrane 
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fusion, since mutat ion of the A T P binding sites eliminates 
both ATPase activity and fusion [6-9]. 
Several lines of evidence strongly support the S N A R E hy-
pothesis: (1) v-SNAREs and t -SNAREs make a stable com-
plex in cell lysates prepared with non-ionic detergents; (2) 
fatal neurotoxins such as tetanus and botulinum toxins spe-
cifically cleave these S N A R E proteins and inhibit exocyto-
sis[l 1 1 3 ] ; and (3) the depletion of homologs of these S N A R E 
proteins inhibits various steps of vesicle transport in yeast 
[14]. 
Although proteins of the S N A R E complex are widely dis-
tributed among eukaryotic cells, in mammals only neuronal 
and endocrine cells have so far been fully established to have 
both v-SNAREs and t -SNAREs for exocytosis [15-18]. In 
exocrine cells, including parotid acinar cells, VAMP-2 of v-
SNAREs has been identified, but brain-type t -SNAREs have 
not been detected [19,20]. Recently, however, tetanus toxin 
and botul inum toxin B, both of which specifically hydrolyze 
VAMP-2, inhibited amylase release from streptolysin-O per-
meabilized pancreatic [21] and parotid acinar cells [22], sug-
gesting that the S N A R E hypothesis is also applicable to exo-
crine glands. Therefore, in this study we have examined 
whether or not the S N A R E complex is formed in the lysate 
of parotid acinar cells. 
2. Materials and methods 
2.1. Materials 
Anti-rat VAMP-2 antibody (rabbit IgG, polyclonal), anti-rat syn-
taxin (monoclonal) and anti-rat SNAP-25 (monoclonal) antibodies 
were purchased from Wako (Osaka, Japan). Anti-NSF (monoclonal) 
was prepared as described previously [6] and anti-aSNAP (rabbit IgG, 
polyclonal) antibody was raised against His-tag aSNAP. Pefabloc SC 
was from Merck (Darmstadt, Germany). Enhanced chemilumines-
cence (ECL) kit was from Amersham (Little Chalfont, England). 
Block Ace was from Dainippon Seiyaku (Osaka, Japan). All other 
chemicals utilized were the highest grade commercially available. 
2.2. Immunoprecipitation and immunoblotting 
Rat parotid acinar cells (small acini) were prepared as described 
earlier [23,24]. Parotid acini were pelleted and lysed with 0.5 ml 
PBS containing 1% Triton X-100, 2 mM DTT, and 0.2 mM Pefabloc 
SC on ice for 30 min. The lysate was centrifuged at 15 000 rpm for 
5 min at 4°C, and aliquots of the supernatant (100 jxl) were incubated 
with either 0.5 mM ATP+2 mM MgS04 or 0.5 mM ATP+2 mM 
EDTA at 4°C for 30 min. After incubation, the mixture was diluted 
10-fold with the incubation medium without Triton X-100; and then 
anti-VAMP-2 antibody or control rabbit IgG was added to it. After 
the mixture had been rotated at 4°C for 1 h, the antigen-antibody 
complex was recovered with protein A Sepharose beads and washed 
5 timed with the incubation medium without Triton X-100. The beads 
were boiled for 5 min in the Laemmli cocktail. 
Proteins in the immunoprecipitate were resolved by SDS-PAGE on 
a 5-20% gradient gel (Atto, Tokyo). Proteins in the gel were trans-
ferred to a PVDF membrane at 100 mA per mini-gel (90X73X 1 mm) 
for 60 min with a semi-dry blotter using 0.1 M Tris-0.192 M glycine 
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buffer containing 5% methanol. The membrane was washed twice with 
water, blocked with Block Ace at room temperature for 1 h, and 
incubated with properly diluted primary antibody in PBS containing 
0.05% Tween 20 and 20% Block Ace for 1 h at room temperature or 
overnight at 4°C. SNARE proteins were then visualized by the ECL 
system. 
3. Results and discussion 
Hayashi et al. reported that the binding between v-
SNAREs and t-SNAREs in rat brain lysates is maintained 
during SDS-PAGE unless the sample in the Laemmli cocktail 
is boiled [4,10]. This point was confirmed in this study (Fig. 
1). When the sample was not boiled, monomers of syntaxin 
and SNAP-25 were markedly decreased, and the high molec-
ular mass complexes of these t-SNAREs were clearly seen. On 
the other hand, the monomer of VAMP-2 was not markedly 
decreased in the same sample, although the high molecular 
complexes were clearly detected. These results suggest that 
either (1) the binding between VAMP-2 and t-SNAREs is 
less stable in Laemmli cocktail than that between syntaxin 
and SNAP-25 or (2) VAMP-2 is in relative excess for making 
SNARE complexes compared with t-SNAREs or both. Fur-
thermore, among bands of the high molecular mass com-
plexes, the relative intensity of syntaxin, SNAP-25, and 
VAMP-2 varied greatly, indicating that these SNARE com-
plexes are heterogeneous in their composition. 
Although brain-type t-SNAREs do not exist in parotid aci-
ni, high molecular mass complexes of VAMP-2 should be 
detected in the non-heated sample, if similar SNARE com-
plexes are formed in parotid acinar cell lysates. However, we 
could only detect the monomeric VAMP-2, but not the high 
molecular mass complex of VAMP-2 even when a large 
amount of proteins was subjected to SDS-PAGE and the 
immunoblots were exposed for a long time to detect weak 
Fig. 1. SNARE complexes in rat brain and parotid acinar cell ly-
sates. Rat brain and parotid acini were homogenized with PBS con-
taining 1% Triton X-100, 2 mM DTT, 2 mM EDTA and 0.2 mM 
Pefabloc SC in a Teflon-glass homogenizer. The lysate was kept on 
ice for 30 min and then centrifuged at 15 000 rpm for 5 min at 4°C. 
Aliquots of the supernatant were mixed with the Laemmli cocktail 
and kept at room temperature or boiled for 5 min. The boiled sam-
ple was re-boiled just before SDS-PAGE. After SDS-PAGE, 
SNARE proteins were visualized by immunoblotting with the ECL 
system. 
Fig. 2. Detection of NSF in brain and parotid acinar cell lysates. 
The lysates were prepared as described in the legend to Fig. 1, ex-
cept that parotid acini were homogenized with the buffer without 
EDTA. After centrifugation, lysates of parotid acini were incubated 
with either 0.5 mM ATP+2 mM MgS04 or 0.5 mM ATP+2 mM 
EDTA at 4°C for 30 min. Aliquots of the lysates were mixed with 
the Laemmli cocktail and kept at room temperature or boiled for 
5 min. After SDS-PAGE, NSF was visualized by immunoblotting. 
signal of VAMP-2 (Fig. 1). A faint band seen at a molecular 
mass of 50 kDa was a non-specific one that was observed even 
if blots of parotid lysates were incubated with the secondary 
antibody for rabbit IgG without primary antibodies (data not 
shown). These results suggest that the binding between 
VAMP-2 and t-SNAREs in parotid acini is less stable than 
that in brain. 
Parotid acinar cells was found to contain NSF and ocSNAP 
(Figs. 2 and 3). NSF and SNAPs are believed to be ubiquitous 
components of SNARE complexes in all vesicle transport, 
including exocytosis. In this study, even when the Laemmli 
cocktail was not boiled, NSF in both brain and parotid acini 
was only detected as a monomer irrespective of the presence 
or absence of Mg-ATP. 
Next we tried to isolate SNARE complexes by immunopre-
cipitation with anti-VAMP-2 antibody. Since the antigen-anti-
body complex of VAMP-2 was fairly unstable in the presence 
of 1% Triton X-100, we incubated anti-VAMP-2 with a 10-
fold diluted lysate of parotid acini (0.1% Triton X-100). As 
shown in Fig. 3, VAMP-2 was precipitated only with anti-
VAMP-2 antibody, but not with control rabbit IgG or protein 
A Sepharose beads alone, indicating that the immunoprecipi-
tation is specific and that the washing process completely re-
moved unbound VAMP-2. The recovery of VAMP-2 with 
anti-VAMP-2 antibody was almost complete, since we could 
not detect VAMP-2 in 10-fold concentrated supernatant. 
Then we examined the existence of NSF and ocSNAP in the 
immunoprecipitate obtained with anti-VAMP-2. As shown in 
Fig. 3, NSF was coprecipitated with VAMP-2, and was com-
pletely removed from the immunoprecipitate in the presence 
of Mg-ATP. The Mg-ATP-dependent release of NSF from the 
SNARE complex is the most characteristic behavior of this 
protein [1,2]. ocSNAP was also coprecipitated with VAMP-2 
and was released from the immunoprecipitate in the presence 
of Mg-ATP. aSNAP is recognized to be released from the 
SNARE complex only in the presence of both NSF and 
Mg-ATP [4,5]. In the latter experiment the background reac-
tion was very high, since antibodies for VAMP-2 and ocSNAP 
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Fig. 3. Coprecipitation of NSF and osSNAP by immunoprecipitation 
with anti-VAMP-2 antibody. The immunoprecipitation was per-
formed as described in Section 2. Lysates of parotid acini and brain 
were prepared as described in the legend to Fig. 1. After SDS-
PAGE, NSF, VAMP-2, and aSNAP were visualized by immuno-
blotting. Lane 1, protein A Sepharose beads alone; lane 2, control 
rabbit IgG; lane 3, anti-VAMP-2 antibody incubated with 0.5 mM 
ATP+2 mM EDTA; lane 4, anti-VAMP-2 antibody incubated with 
0.5 mM ATP+2 mM MgS04 . Br, brain; Pa, parotid acinar cells. 
were both polyclonal rabbit IgG and the molecular mass of 
ocSNAP (35 kDa) was just between the masses of heavy and 
light chains of anti-VAMP-2 that were used for immunopre-
cipitation. 
The present study clearly shows that the antibody for 
VAMP-2 coprecipitates N S F and a S N A P , essential compo-
nents of membrane fusion in various steps of vesicle trans-
ports. In vitro study reveals that N S F and a S N A P are unable 
to bind directly to VAMP-2, but bind indirectly via t-
SNAREs that bind to VAMP-2 [4,5]. Recently the c D N A of 
SNAP-23, a new homolog of SNAP-25, was cloned from a 
human B lymphocyte c D N A library by use of the yeast two-
hybrid system, in which syntaxin 4 was used as the 'bait ' [25]. 
Nor thern blot analysis revealed that SNAP-23 is ubiquitously 
expressed in many human tissues, including pancreas [25]. 
Thus, it is very likely that rat parotid glands also contain 
the rat counterpart of SNAP-23. In addition, syntaxin 4 is 
also expressed widely in non-neuronal cells [26] and is specif-
ically located on the plasma membrane [27]. These results and 
our present findings collectively suggest that the immunopre-
cipitate obtained with anti-VAMP-2 contains unidentified t-
SNAREs of the rat parotid acinar cells in addition to N S F 
and a S N A P . Further study is necessary to identify t -SNAREs 
in parot id acinar cells. 
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